Privacy and Data Security
Posted: Tue May 20, 2025 8:48 am
Fraud Prevention: It helps identify individuals who might attempt to fraudulently assume the credentials of other physicians, including deceased physicians (AMA maintains records of deceased physicians for this purpose).
Research: Academic, government, and private sector research projects use the data for statistical analysis and market research (often in de-identified or aggregated formats).
Commercial Use (with restrictions): The AMA licenses this data to Health Information Organizations (HIOs) and data mining companies (like IQVIA). These companies may then combine it with other data, such as prescribing data (which the AMA itself does NOT collect or sell), and provide it to pharmaceutical companies for marketing purposes.
AMA Physician Data Restriction night clubs and bars email list Program (PDRP)
This is a crucial program that gives physicians control over how their prescribing data (which, again, the AMA doesn't collect) is used by pharmaceutical sales representatives.
Purpose: To allow physicians to opt-out of having their individual prescribing data accessed by pharmaceutical sales representatives ("detailers").
How it works: Physicians can register through the AMA PDRP website to restrict this specific use of their data.
Why the AMA offers it: While the AMA doesn't collect prescribing data, HIOs often use AMA demographic data in conjunction with prescribing data. By licensing their demographic data to HIOs, the AMA can enforce contractual requirements for HIOs to respect physician choices made through the PDRP.
Benefits: It empowers physicians with choice and helps ensure that prescribing data remains available for public health benefits like drug recalls, evidence-based medical research, and structuring clinical trials, even if it's restricted for sales purposes.
Research: Academic, government, and private sector research projects use the data for statistical analysis and market research (often in de-identified or aggregated formats).
Commercial Use (with restrictions): The AMA licenses this data to Health Information Organizations (HIOs) and data mining companies (like IQVIA). These companies may then combine it with other data, such as prescribing data (which the AMA itself does NOT collect or sell), and provide it to pharmaceutical companies for marketing purposes.
AMA Physician Data Restriction night clubs and bars email list Program (PDRP)
This is a crucial program that gives physicians control over how their prescribing data (which, again, the AMA doesn't collect) is used by pharmaceutical sales representatives.
Purpose: To allow physicians to opt-out of having their individual prescribing data accessed by pharmaceutical sales representatives ("detailers").
How it works: Physicians can register through the AMA PDRP website to restrict this specific use of their data.
Why the AMA offers it: While the AMA doesn't collect prescribing data, HIOs often use AMA demographic data in conjunction with prescribing data. By licensing their demographic data to HIOs, the AMA can enforce contractual requirements for HIOs to respect physician choices made through the PDRP.
Benefits: It empowers physicians with choice and helps ensure that prescribing data remains available for public health benefits like drug recalls, evidence-based medical research, and structuring clinical trials, even if it's restricted for sales purposes.